⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
FBIO News
Fortress Biotech, Inc.
Journey Medical Corporation Announces Publication of Clinical Trial Results Assessing the Impact of Emrosi™ (DFD-29) on Microbial Flora of Healthy Adults in the Journal of Drugs in Dermatology
globenewswire.com
DERM
FBIO
Fortress Biotech Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights
globenewswire.com
FBIO
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Palantir Technologies Inc. - PLTR
accessnewswire.com
FBIO
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fortress Biotech Inc. - FBIO
accessnewswire.com
FBIO
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fortress Biotech Inc. - FBIO
accessnewswire.com
FBIO
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Palantir Technologies Inc. - PLTR
accessnewswire.com
FBIO
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fortress Biotech Inc. - FBIO
prnewswire.com
FBIO
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fortress Biotech Inc. - FBIO
prnewswire.com
FBIO
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fortress Biotech Inc. - FBIO
prnewswire.com
FBIO
Fortress Biotech and Cyprium Therapeutics Announce an Update on the NDA for CUTX-101
globenewswire.com
FBIO